The Translational Genomics Research Institute Foundation
The Translational Genomics Research Institute Foundation reported $11.6 million in revenue and $8.7 million in expenses for the fiscal year ending September 30, 2025. Of every $100 it spent, $83.66 went to program services, $1.69 to management and general costs and $14.65 to fundraising. Its largest source of revenue was contributions and grants: 92.7% of the total. The highest compensation it reported for one person was $2,031,265 (BOARD MEMBER). Revenue fell 50% between FY2020 and FY2025. Source: Form 990, FY2025.
Where $100 of spending went
The fiscal year ending September 30, 2025 · Form 990, Part IX, line 25 · total expenses $8.7MFor context, the median across 169 covered medical research charities: $87.02 programs, $12.87 management, $0.11 fundraising (medians computed separately, so they may not sum to $100).
Where $100 of revenue came from
The fiscal year ending September 30, 2025 · Form 990, Part VIII · total revenue $12MThe 990 scorecard · same measures for every charity, no grades
| Measure | FY2025 | Median |
|---|---|---|
| Program services Part IX 25(B) ÷ 25(A) | 83.7% | 83.9% |
| Management & general Part IX 25(C) ÷ 25(A) | 1.7% | 12.4% |
| Fundraising Part IX 25(D) ÷ 25(A) | 14.7% | 0.1% |
| Fundraising cost per $1 of contributions Part IX 25(D) ÷ Part VIII 1h | $0.12 | $0.01 |
| Contributions & grants share of revenue Part VIII 1h ÷ 12 | 92.7% | 72.7% |
| Government grants share of revenue Part VIII 1e ÷ 12 | 0.0% | 0.0% |
| Program service revenue share Part VIII 2g ÷ 12 | 0.0% | 5.8% |
| Highest reported compensation Part VII-A, columns D–F | $2,031,265 | $628,890 |
| Highest compensation as share of expenses Part VII-A ÷ Part IX 25(A) | 23.38% | 1.94% |
| People paid over $100,000 Part VII, line 2 | 0 | 18 |
| Net assets, in months of expenses Part X 33(B) ÷ monthly expenses | 20.7 | 13.3 |
| Independent voting board members Part VI 1a–1b | 19 of 23 | 93.8% |
A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.
What the money paid for, in its own words
FY2025 · Form 990, Part III · the three largest programs by expenseHighest reported compensation
FY2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here| Role | From this org | From related orgs | Other | Total |
|---|---|---|---|---|
| BOARD MEMBER Director/trustee, 1.0 hrs/week | $0 | $1,780,335 | $250,930 | $2,031,265 |
| BOARD MEMBER/TGEN COO Director/trustee, 1.0 hrs/week | $0 | $873,875 | $78,630 | $952,505 |
| BOARD MEMBER (PT YR) Director/trustee, 1.0 hrs/week | $0 | $532,189 | $44,201 | $576,390 |
| CHIEF DEVELOPMENT OFFICER Director/trustee, officer, 40.0 hrs/week | $0 | $377,428 | $23,737 | $401,165 |
0 people received more than $100,000 in reportable compensation from The Translational Genomics Research Institute Foundation (Part VII, line 2). Compensation of current officers, directors and key employees totaled $363K (Part IX, line 5).
6 years of filings
Form 990, Parts I, VII, IX and X · each row is that year's own filing, linkedGovernance answers, as filed
FY2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means- Voting board members, and how many are independent Part VI, lines 1a–1b23 · 19 independent
- Audited financial statements Part XII 2bYes
- Conflict-of-interest policy Part VI 12aYes
- Whistleblower policy Part VI 13Yes
- Document retention policy Part VI 14Yes
- Independent process for top executive pay Part VI 15aNo
- Board given the 990 before filing Part VI 11aYes
- Family or business ties among insiders Part VI 2Yes
- Aware of a significant diversion of assets Part VI 5No
- Excess benefit transaction with an insider Part IV 25aNo
- Loans to or from insiders outstanding Part IV 26No
- Lobbying, or a 501(h) election in effect Part IV 4No
- Over $15,000 of professional fundraising services Part IV 18No
- Over $10,000 of activity outside the U.S. Part IV 14bNo
- Employees Part I, line 50
- Volunteers Part I, line 6105
Private foundation grants it received
5 private foundations reported grants to The Translational Genomics Research Institute Foundation totaling $5.9M on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.
Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.
Correct a figure or respond
Every number above is copied from The Translational Genomics Research Institute Foundation's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for The Translational Genomics Research Institute Foundation, you can publish a response that is linked from this page.
Share or embed this breakdown
Of every $100 The Translational Genomics Research Institute Foundation spent in FY2025, $83.66 went to programs. The full breakdown, from its IRS Form 990:
Embed on your site
Similar-sized charities in this cause
- Immune Deficiency FoundationHanover, MD · revenue $11M · programs 70.1% · 2025
- Count Me inCambridge, MA · revenue $12M · programs 62.8% · FY2023
- Cancer Research and BiostatisticsSeattle, WA · revenue $11M · programs 68.6% · 2024
- International Myeloma SocietyBoston, MA · revenue $12M · programs 94.1% · 2024
- FH Enterprise Services HoldingsMilwaukee, WI · revenue $11M · programs 55.3% · FY2025
All medical research charities · Largest charities in Arizona
Questions people ask
How much of The Translational Genomics Research Institute Foundation's spending goes to programs?
In the fiscal year ending September 30, 2025, The Translational Genomics Research Institute Foundation reported that 83.7% of its $8.7 million in expenses went to program services, 1.7% to management and general and 14.7% to fundraising (Form 990, Part IX).
How much does The Translational Genomics Research Institute Foundation pay its top executive?
The largest total compensation The Translational Genomics Research Institute Foundation reported for one person in the fiscal year ending September 30, 2025 was $2,031,265, for the role of BOARD MEMBER (Form 990, Part VII, including compensation from related organizations and other compensation).
Where does The Translational Genomics Research Institute Foundation get its money?
Of $11.6 million in revenue in the fiscal year ending September 30, 2025, 92.7% came from contributions and grants and 0.0% from program service revenue (Form 990, Part VIII).
Is The Translational Genomics Research Institute Foundation a registered charity?
The IRS lists EIN 33-1092191 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.
Sources
- FY2025: Form 990 for the fiscal year ending September 30, 2025, object 202612259349302196 · read the filing
- FY2024: Form 990 for the fiscal year ending September 30, 2024, object 202502259349302200 · read the filing
- FY2023: Form 990 for the fiscal year ending September 30, 2023, object 202442269349300929 · read the filing
- FY2022: Form 990 for the fiscal year ending September 30, 2022, object 202312269349302636 · read the filing
- FY2021: Form 990 for the fiscal year ending September 30, 2021, object 202232209349301543 · read the filing
- FY2020: Form 990 for the fiscal year ending September 30, 2020, object 202142249349301894 · read the filing
All filings for EIN 33-1092191: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.